Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Osato Research Corp. is a biotechnology company specializing in the development and clinical validation of fermented functional foods, primarily focusing on its flagship product, Immun'Âge. This Fermented Papaya Preparation (FPP) is produced through a proprietary multi-month yeast fermentation process designed to enhance antioxidant and immunomodulatory properties. The company is distinguished by its commitment to rigorous scientific research, collaborating with international institutions and Nobel laureates to study the effects of FPP on oxidative stress and chronic diseases. Their research portfolio includes investigations into diabetes management, neurodegenerative protection, and the mitigation of environmental stressors like electromagnetic fields. Osato's products are manufactured in Japan under strict international quality standards and are distributed globally to support healthy aging and immune function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Osato Research Corp..